8
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
article
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Possible Solutions Webinar Summary
Antimicrobial resistance (AMR) poses a threat to everyone. However, some patients with chronic illne
sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.
+ Read More
article
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US Senate HELP Committee
Submitted electronically
article
Center for Public Health: Spring 2023 Newsletter
In This Newsletter
Programs at a Glance
Policy Updates
CPH in the Community
In Case You Missed It
W
hat’s Ahead
+ Read More
article
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US House Energy & Commerce Committee
Submitted electronically
article
TRAIN Newsletter — March 2023
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
+ Read More